Avid Bioservices Inc (CDMO)

[sunstar]

BAVITUXIMAB BREAST CANCER COMPLETE RESPONSES WERE ABSOLUTELY REMARKABLE.

Complete Response (CR) means the disappearance of all signs of cancer in response to the treatment; the tumors are gone.

Peregrine just ran two Phase 2 breast cancer trials using bavituximab with two different chemotherapies.

Bavi Complete Responses (CR) were 21.7% and 19.5%

Avastin has reported: ZERO!

Bavi Overall Responses Rates (ORR): 74% and 61%

Avastin approval reported (ORR): 37%

No other treatment regime being currently used to treat breast cancer even comes close to what bavituximab has just done

NOTHING ELSE COMES CLOSE.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=51223587

http://www.peregrineinc.com/media/siteFiles/Peregrine702.pdf

http://www.peregrineinc.com/media/siteFiles/Peregrine704.pdf

sunstar